Balsu Gıda offers listed equity exposure to hazelnut processing and supply, rather than a direct investment in the crop itself. The company supplies ingredients to chocolate, confectionery and other food manufacturers. Its shares began trading on February 20, 2025, under the ticker BALSU, confirmed in the Borsa İstanbul listing announcement.
The investment question is whether Balsu can earn satisfactory returns after paying for raw materials, inventory, borrowing and expansion. Higher hazelnut prices do not automatically help. They can raise the value of sales while absorbing cash and discouraging customers from placing orders.
For the wider supply and demand background, see our guide to Turkish hazelnut exports, pricing and investment exposure. This article focuses on Balsu’s business, financial statements and shareholder risks, using disclosures available through October 19, 2026.
What BALSU Shareholders Own
Balsu’s business combines procurement, processing and distribution. Its Turkish operations include facilities in Hendek, Sakarya, and Ordu. Products include hazelnut kernels, flour, granules and paste. The group also has overseas subsidiaries, including agricultural and processing businesses in Chile.
At June 30, 2026, BG Holding held 455.15 million shares out of paid capital of 1.112 billion Turkish lira, equivalent to approximately 40.93%. These operating and ownership details appear in the Balsu annual report for the year ended June 30, 2026.
That structure matters in two ways. Shareholders own an operating group with factories, customer relationships, working capital and investment commitments, not a warehouse of hazelnuts that simply rises with commodity prices. They also invest alongside a substantial shareholder whose decisions on funding and capital allocation deserve close attention.
Do not treat the existence of overseas subsidiaries as proof of geographic diversification in earnings. A sales office, an orchard and a processing factory perform different jobs. Their contribution should be assessed through revenue, operating profit, cash requirements and the capital tied up in each activity.
How Balsu’s Business Can Make Money
The simplest way to assess a processor is to separate the value of its raw materials from the value it adds. Procurement, sorting, processing, storage and delivery all cost money. The commercial question is whether customers pay enough above those costs to leave an attractive return.
Product mix deserves attention. Selling a kernel and supplying an ingredient prepared for a manufacturer’s production line can involve different equipment, quality requirements and customer service. More processing can support a higher selling price, but it also brings extra costs. A larger invoice is not, by itself, a better margin.
Price Pass Through and Contract Timing
Consider a hypothetical order priced before a sharp rise in procurement costs. If the processor has not secured the required hazelnuts, fulfilling that order may become less profitable. Buying the raw material early reduces that exposure, but creates storage and financing costs instead.
The reverse can also hurt. Expensive inventory bought during a shortage may become harder to sell profitably if market prices fall. Matching purchases, customer commitments and financing is therefore more useful than taking a simple bullish or bearish view on hazelnuts.
Customer Relationships and Concentration
A long commercial relationship can support repeat orders, but it does not remove bargaining pressure. Assess whether sales depend heavily on a few customers, how payment terms change, and whether receivables grow faster than revenue. Avoid assuming that supplying prominent food manufacturers guarantees either pricing power or prompt cash collection.
Reading Balsu’s Financial Results Correctly
Balsu uses a financial year ending June 30. Its 2025/2026 annual results cover July 1, 2025, through June 30, 2026, rather than the 2025 calendar year. The following rounded figures come from its audited consolidated financial statements for 2025/2026. Both columns are expressed in June 30, 2026 purchasing power.
| Measure | 2025/2026 | 2024/2025, restated |
|---|---|---|
| Revenue | 22.616 | 22.978 |
| Gross profit | 3.670 | 3.554 |
| Operating profit | 2.702 | 2.536 |
| Net profit | 0.254 | 0.627 |
| Net cash from operating activities | -1.558 | -6.440 |
The results show why operating performance and shareholder earnings need separate treatment. Operating profit increased, but net profit fell. The group recorded a loss before tax; a deferred tax credit brought the final result into profit. Operating cash flow remained negative.
For investment analysis, that combination calls for a bridge between operating profit, financing costs, tax effects and cash generation. A positive earnings figure does not establish that cash is available for dividends, debt repayment or another factory.
Negative operating cash flow is not enough, on its own, to reject a seasonal processor. The reason matters. Ask whether cash funded saleable inventory and collectible receivables, or whether stocks and customer balances are taking longer to turn into money. Then examine whether the following reporting periods show a release of that cash.
Keep the Inflation Basis Consistent
Use the comparative figures inside the same financial report when measuring annual changes. Comparing a newly restated number with an older headline copied from a previous announcement can create a misleading growth rate.
Our guide to inflation accounting in Turkish financial statements covers the broader accounting issues. For Balsu, the practical discipline is straightforward: label the reporting period, currency and purchasing power basis before calculating a margin or valuation multiple. The spreadsheet will accept inconsistent inputs without complaint. That is not an endorsement.
Working Capital and Financing Deserve Particular Attention
Inventory can protect delivery commitments while putting pressure on the balance sheet. The relevant calculation is not just tonnes held, but the cash cost of carrying them and the time until customers pay.
Use a hypothetical example. If a processor carries inventory costing 100 million lira and replacement prices double, maintaining the same physical stock could require another 100 million lira. No additional factory output is needed for the funding requirement to rise. Longer customer payment terms could stretch it further.
This is why an apparently profitable processor can still need fresh capital. Track inventory days, receivable days and supplier payment terms together. A reduction in borrowing funded by collected customer balances is different from a reduction funded by new shareholder money.
Balsu disclosed that BG Holding transferred TRY4.64 billion to the company on July 2, 2026, as a capital advance, with an application to convert it into share capital through a private placement submitted on July 7. The company’s September 11 disclosure described that conversion as subject to regulatory approval. It also set out management expectations for roughly 60% lower indebtedness and 70% lower financing expenses in 2026/2027. These were forecasts, not achieved results, in the Balsu financial review and forward outlook.
The timing is important: a July cash transfer falls after the June year end. Do not insert it into the published June balance sheet as though it had already occurred. Any adjusted analysis should show the reported position first, followed by a clearly labelled subsequent funding adjustment.
For a proposed share issue, examine the final issue price, number of new shares and resulting ownership percentages. More cash can strengthen the company while a larger share count changes each existing shareholder’s claim on future earnings. Balance sheet improvement and per share value creation are related, but they are not interchangeable.
Chile and Hendex Add Different Investment Risks
Balsu is pursuing more than Turkish hazelnut processing. Its chairman’s September 20, 2026 statement described the Chilean processing investment as entering operation in stages during 2026. It also reported that trial production for the hazelnut shell activated carbon project had begun on December 26, 2025, with preparations continuing for higher volume production. These milestones appear in the chairman’s statement on operations and investment progress.
Chile: Assess the Return, Not Just the Footprint
The analytical case for another production location should rest on what it contributes: access to raw materials, customer service, processing income and cash generation. A foreign factory is not diversification simply because it has a foreign address.
Separate commissioning from commercial success. Equipment installation, first production, repeat customer orders and satisfactory returns are different milestones. During an initial operating period, ask how much further capital is required and whether the business can fund its own working capital.
A useful assessment would compare actual production, utilisation and margins with the investment case. Avoid assigning a mature earnings multiple to a plant that has not yet demonstrated mature earnings.
Hendex: Treat Activated Carbon as a Separate Business Case
The Hendex project needs its own valuation assumptions. Turning hazelnut shells into an industrial product may create another revenue stream, but it should not receive a valuation premium solely because the raw material comes from the existing business.
Request evidence of repeat sales, realised selling prices, production yields, energy costs and customer acceptance. Distinguish shell input capacity from finished product output: the two quantities answer different questions. Also separate trial sales from a dependable commercial run rate.
For a cautious valuation, calculate the value of the established processing operation first. Then assess Hendex under several outcomes, including a slower production ramp and further spending. This makes the cost of optimism visible rather than burying it in one group growth assumption.
Do Not Confuse International Reach With Export Revenue
An investment thesis built around exports needs evidence about where sales arise and which activities generate them. Domestic sales to a manufacturer serving international markets are not automatically the processor’s own exports. Sales through a foreign subsidiary also require care: its sales location and production location may differ.
Use consistent definitions when comparing Balsu with other food companies. Revenue geography, customer destination and production geography can each tell a useful story, but they should not be substituted for one another.
Our guide to export revenue versus overseas production explains this distinction. For a shareholder, the practical question is which operations generate cash and which currencies determine their receipts, procurement costs and debt service.
How to Build a Balsu Valuation
Start with a current share price and the applicable share count. Check completed capital changes before calculating market capitalisation. Then build enterprise value using a consistent treatment of cash, financial borrowing and other financing obligations.
Do not rely on a single price to earnings ratio. An earnings figure affected by financing pressure or a tax credit may be a poor estimate of repeatable profit. Equally, an operating earnings multiple can hide the cash cost of carrying inventory.
A practical valuation should test three cases:
- A stable case: processing margins hold, working capital turns at a reasonable pace, and expansion contributes gradually.
- A recovery case: customer orders convert into cash more quickly, reducing borrowing and financing costs.
- A stress case: inventory remains expensive, collections slow, and new operations need more funding before generating cash.
Keep the assumptions connected. It is inconsistent to forecast rapid sales growth, falling inventory and lower borrowing without explaining how procurement and customer payments support all three.
Our framework for comparing Turkish food stocks using valuation and cash flow provides the broader method. For Balsu, give particular weight to cash conversion and the return on new investment, rather than adding the full value of every announced capacity target.
What Would Strengthen the Investment Case?
The strongest evidence would be repeatable operating earnings turning into cash, lower funding needs without persistent dilution, and new facilities earning acceptable returns on the money invested.
Balsu should therefore be assessed as a processor with seasonal funding demands and expansion commitments, not as a simple bet on hazelnut prices. The useful question is not whether the industry can grow. It is how much of that growth reaches each share after raw materials, financing and capital spending have been paid for.